Here, we show that mutant receptors mis-localize in solid tumor using a panel of cancer tissues from GIST patients, and that Kit(mut) must localize to the Golgi to cause oncogenic activation of the PI3K–Akt pathway, STAT5 and Erk. The gene discussed is KIT; the disease is cancer.